Related Experiment Video
Updated: Jan 8, 2026

09:57
Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung
Published on: November 16, 2021
7.6K
Optimized protocol for processing murine tumor-bearing lung tissue for flow cytometry and single cell RNA-sequencing
Sicong Wang1, Anastasiia Ivanova1, Helen P Makarenkova1
1The Scripps Research Institute, Department of Molecular and Cellular Biology.
Biorxiv : the Preprint Server for Biology
|December 15, 2025
Summary
This study presents a new protocol for isolating high-quality single cells from mouse lung tissue, crucial for understanding non-small cell lung cancer (NSCLC) heterogeneity using single-cell RNA sequencing.
Area of Science:
- Molecular Biology
- Oncology
- Genomics
Background:
- Non-small cell lung cancer (NSCLC) is the most common lung cancer, with KRAS mutations frequent.
- Tumor heterogeneity and plasticity in NSCLC remain poorly understood.
- Single-cell RNA sequencing (scRNA-seq) is vital for studying cellular heterogeneity.
Purpose of the Study:
- To develop a robust protocol for isolating high-quality single-cell suspensions from healthy and tumor-bearing mouse lungs.
- To enable effective scRNA-seq analysis of lung cancer models.
- To facilitate the study of NSCLC heterogeneity and Kras-driven tumorigenesis.
Main Methods:
- Detailed protocol for single-cell suspension preparation from mouse lungs.
- Includes tissue perfusion, enzymatic digestion, mechanical dissociation, RBC lysis, and filtration.
- Utilizes a KrasG12D; tdTomato reporter mouse model for tumor cell identification.
Main Results:
- Achieved >85% viable single cells suitable for scRNA-seq.
- Successfully isolated tdTomato+ tumor cells using Fluorescence-Activated Cell Sorting (FACS).
- Demonstrated distinct tumor cell clusters in scRNA-seq analysis.
Conclusions:
- The developed protocol yields high-quality single-cell suspensions from complex lung tissues.
- This method is essential for advancing scRNA-seq studies in NSCLC research.
- Enables detailed investigation of Kras-mutant lung cancer biology at the single-cell level.

